| 000 | 01745 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516100250.0 | ||
| 264 | 0 | _c20121026 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1091-6490 | ||
| 024 | 7 |
_a10.1073/pnas.1200024109 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTudor, Daniela | |
| 245 | 0 | 0 |
_aIsotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cJul 2012 |
||
| 300 |
_a12680-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _ximmunology |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xgenetics |
| 650 | 0 | 4 |
_aAntibodies, Neutralizing _xgenetics |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aEpitopes _xgenetics |
| 650 | 0 | 4 |
_aHIV Antibodies _xgenetics |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp41 _xgenetics |
| 650 | 0 | 4 |
_aHIV-1 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xgenetics |
| 650 | 0 | 4 | _aProtein Structure, Secondary |
| 650 | 0 | 4 |
_aTranscytosis _xdrug effects |
| 700 | 1 | _aYu, Huifeng | |
| 700 | 1 | _aMaupetit, Julien | |
| 700 | 1 | _aDrillet, Anne-Sophie | |
| 700 | 1 | _aBouceba, Tahar | |
| 700 | 1 | _aSchwartz-Cornil, Isabelle | |
| 700 | 1 | _aLopalco, Lucia | |
| 700 | 1 | _aTuffery, Pierre | |
| 700 | 1 | _aBomsel, Morgane | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 109 _gno. 31 _gp. 12680-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.1200024109 _zAvailable from publisher's website |
| 999 |
_c21886607 _d21886607 |
||